ASEPTIC MANUFACTURING AND CONTAMINATION CONTROL OF BIOMEDICAL MICRO/NANOROBOTS AT THE LIMIT Aseptic Process x Contamination Monitoring x Functional Integrity This 770-page Research Working Edition develops a falsification-oriented, nonclinical architecture for reducing and localizing microbial, endotoxin, particle and cross-batch contamination while preserving biomedical micro/nanorobot material and task function. It distinguishes low observed counts from qualified control and treats burden, sampling recovery, assay interference, transport, source localization, uncertainty and independent function as separate scientific objects. The monograph contains 30 mathematical research plates, 82 chapters, 410 single-page investigations, 200 differentiated Research Gates and 33 genuinely distinguishable Phoenix Answer Embryos. Its minimum demonstrator blind-injects three contamination routes into a closed microfluidic line and tests whether an independent team detects and localizes them before release. Unqualified recovery, unlocalized contamination, a nonclosing material balance or function loss is a hard veto. This is a prospective scientific architecture, not an executed clinical or regulatory study. It does not claim in-use sterility, in-body safety, therapeutic efficacy, regulatory approval or clinical benefit. DOI-linked publications support component methods and boundaries; they do not validate the integrated F26 system. Technical profile: 770 pages; approximately 161,936 English words; 30 formula families; 82 chapters; 410 single-page studies; 200 Research Gates; 33 Phoenix Answer Embryos; 22 DOI records; navigable bookmarks; sixfold QA. Author: Feng Cheng-en (33) x Starli STARLI Research Institute XXXIV / Flagship 26 Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/

DOI: 10.5281/zenodo.23733536
Published: 2026
Container: Not recorded
Publisher: Zenodo
Open access: yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5281/zenodo.23733536,
  title = {ASEPTIC MANUFACTURING AND CONTAMINATION CONTROL OF BIOMEDICAL MICRO/NANOROBOTS AT THE LIMIT  Aseptic Process x Contamination Monitoring x Functional Integrity  This 770-page Research Working Edition develops a falsification-oriented, nonclinical architecture for reducing and localizing microbial, endotoxin, particle and cross-batch contamination while preserving biomedical micro/nanorobot material and task function. It distinguishes low observed counts from qualified control and treats burden, sampling recovery, assay interference, transport, source localization, uncertainty and independent function as separate scientific objects.  The monograph contains 30 mathematical research plates, 82 chapters, 410 single-page investigations, 200 differentiated Research Gates and 33 genuinely distinguishable Phoenix Answer Embryos. Its minimum demonstrator blind-injects three contamination routes into a closed microfluidic line and tests whether an independent team detects and localizes them before release. Unqualified recovery, unlocalized contamination, a nonclosing material balance or function loss is a hard veto.  This is a prospective scientific architecture, not an executed clinical or regulatory study. It does not claim in-use sterility, in-body safety, therapeutic efficacy, regulatory approval or clinical benefit. DOI-linked publications support component methods and boundaries; they do not validate the integrated F26 system.  Technical profile: 770 pages; approximately 161,936 English words; 30 formula families; 82 chapters; 410 single-page studies; 200 Research Gates; 33 Phoenix Answer Embryos; 22 DOI records; navigable bookmarks; sixfold QA.  Author: Feng Cheng-en (33) x Starli STARLI Research Institute XXXIV / Flagship 26  Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/},
  author = {33},
  year = {2026},
  doi = {10.5281/zenodo.23733536},
  url = {https://doi.org/10.5281/zenodo.23733536}
}

RIS

TY  - JOUR
TI  - ASEPTIC MANUFACTURING AND CONTAMINATION CONTROL OF BIOMEDICAL MICRO/NANOROBOTS AT THE LIMIT  Aseptic Process x Contamination Monitoring x Functional Integrity  This 770-page Research Working Edition develops a falsification-oriented, nonclinical architecture for reducing and localizing microbial, endotoxin, particle and cross-batch contamination while preserving biomedical micro/nanorobot material and task function. It distinguishes low observed counts from qualified control and treats burden, sampling recovery, assay interference, transport, source localization, uncertainty and independent function as separate scientific objects.  The monograph contains 30 mathematical research plates, 82 chapters, 410 single-page investigations, 200 differentiated Research Gates and 33 genuinely distinguishable Phoenix Answer Embryos. Its minimum demonstrator blind-injects three contamination routes into a closed microfluidic line and tests whether an independent team detects and localizes them before release. Unqualified recovery, unlocalized contamination, a nonclosing material balance or function loss is a hard veto.  This is a prospective scientific architecture, not an executed clinical or regulatory study. It does not claim in-use sterility, in-body safety, therapeutic efficacy, regulatory approval or clinical benefit. DOI-linked publications support component methods and boundaries; they do not validate the integrated F26 system.  Technical profile: 770 pages; approximately 161,936 English words; 30 formula families; 82 chapters; 410 single-page studies; 200 Research Gates; 33 Phoenix Answer Embryos; 22 DOI records; navigable bookmarks; sixfold QA.  Author: Feng Cheng-en (33) x Starli STARLI Research Institute XXXIV / Flagship 26  Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/
AU  - 33
PY  - 2026
DO  - 10.5281/zenodo.23733536
UR  - https://doi.org/10.5281/zenodo.23733536
ER  -

APA

33 (2026). ASEPTIC MANUFACTURING AND CONTAMINATION CONTROL OF BIOMEDICAL MICRO/NANOROBOTS AT THE LIMIT Aseptic Process x Contamination Monitoring x Functional Integrity This 770-page Research Working Edition develops a falsification-oriented, nonclinical architecture for reducing and localizing microbial, endotoxin, particle and cross-batch contamination while preserving biomedical micro/nanorobot material and task function. It distinguishes low observed counts from qualified control and treats burden, sampling recovery, assay interference, transport, source localization, uncertainty and independent function as separate scientific objects. The monograph contains 30 mathematical research plates, 82 chapters, 410 single-page investigations, 200 differentiated Research Gates and 33 genuinely distinguishable Phoenix Answer Embryos. Its minimum demonstrator blind-injects three contamination routes into a closed microfluidic line and tests whether an independent team detects and localizes them before release. Unqualified recovery, unlocalized contamination, a nonclosing material balance or function loss is a hard veto. This is a prospective scientific architecture, not an executed clinical or regulatory study. It does not claim in-use sterility, in-body safety, therapeutic efficacy, regulatory approval or clinical benefit. DOI-linked publications support component methods and boundaries; they do not validate the integrated F26 system. Technical profile: 770 pages; approximately 161,936 English words; 30 formula families; 82 chapters; 410 single-page studies; 200 Research Gates; 33 Phoenix Answer Embryos; 22 DOI records; navigable bookmarks; sixfold QA. Author: Feng Cheng-en (33) x Starli STARLI Research Institute XXXIV / Flagship 26 Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/. https://doi.org/10.5281/zenodo.23733536

Source records

datacite · retrieved 2026-11-09T08:17:29.507Z
datacite · retrieved 2026-11-09T08:17:29.507Z